AU3735000A - Modulation of substance p by gaba analogs and methods relating thereto - Google Patents

Modulation of substance p by gaba analogs and methods relating thereto

Info

Publication number: AU3735000A
Authority: AU; Australia
Prior art keywords: modulation; substance; methods relating; gaba analogs; gaba
Prior art date: 1999-05-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU37350/00A

Inventor

Philip John Magistro Jr.

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Warner Lambert Co LLC

Original Assignee

Warner Lambert Co LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-05

Filing date

2000-03-10

Publication date

2000-11-21

2000-03-10 Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC

2000-11-21 Publication of AU3735000A publication Critical patent/AU3735000A/en

Status Abandoned legal-status Critical Current

Links

ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU37350/00A 1999-05-05 2000-03-10 Modulation of substance p by gaba analogs and methods relating thereto Abandoned AU3735000A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13261499P	1999-05-05	1999-05-05
US60132614		1999-05-05
PCT/US2000/006199 WO2000067742A2 (en)	1999-05-05	2000-03-10	Use of gaba analogues for the modulation of substance p

Publications (1)

Publication Number	Publication Date
AU3735000A true AU3735000A (en)	2000-11-21

Family

ID=22454836

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU37350/00A Abandoned AU3735000A (en)	1999-05-05	2000-03-10	Modulation of substance p by gaba analogs and methods relating thereto

Country Status (2)

Country	Link
AU (1)	AU3735000A (en)
WO (1)	WO2000067742A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60034344T2 (en) *	1999-07-22	2008-01-10	University Of Rochester	METHOD FOR TREATING THE SYMPTOMS OF HORMONAL CHANGES, INCLUDING HEAD FORESTS
CA2356829A1 (en) *	2000-09-22	2002-03-22	Warner-Lambert Company	Method for treating asthma using pregabalin
MXPA03009720A (en) *	2001-04-23	2004-01-29	Hoffmann La Roche	Use of nk-1 receptor antagonists against benign prostatic hyperplasia.
EP1572187A1 (en) *	2002-12-13	2005-09-14	Warner-Lambert Company LLC	Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
EP1480631B1 (en) *	2002-12-20	2007-08-01	Dynogen Pharmaceuticals Inc.	Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
US20050043406A1 (en) *	2003-08-22	2005-02-24	Pfizer Inc	Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
WO2008073257A1 (en) *	2006-12-08	2008-06-19	Xenoport, Inc.	Use of prodrugs of gaba analogs for treating diseases
US8686040B2 (en) *	2008-03-31	2014-04-01	Rdd Pharma Ltd.	Method for treating anal pruritis and other perianal disorders
WO2016195723A1 (en) *	2015-06-03	2016-12-08	Beller Pharmaceuticals LLC	Methods of treatment for conditions mediated by substance p

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0934061B3 (en) *	1996-07-24	2015-01-21	Warner-Lambert Company LLC	Isobutylgaba and its derivatives for the treatment of pain

2000
- 2000-03-10 AU AU37350/00A patent/AU3735000A/en not_active Abandoned
- 2000-03-10 WO PCT/US2000/006199 patent/WO2000067742A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2000067742A3 (en)	2001-08-16
WO2000067742A2 (en)	2000-11-16

Similar Documents

Publication	Publication Date	Title
AU6883798A (en)	1998-10-22	Method of anesthesia
AU1345700A (en)	2000-05-29	Method of sterilizing females
AU4005499A (en)	1999-12-20	Method of controlling usage of software components
AU9469198A (en)	1999-05-03	New improved formulation for treatment of osteoporosis
AU5799098A (en)	1998-07-17	Preparation of gabapentin
AU2003281327A1 (en)	2004-01-23	Antisense modulation of tfg-beta 2 expression
AU2001291019A1 (en)	2002-03-26	Method of modulating neovascularization
AU5934598A (en)	1998-09-24	Manufacture of ascorbyl monophosphates
PL338679A1 (en)	2000-11-20	Method of obtaining l-glutamic acid by fermentation
AU3735000A (en)	2000-11-21	Modulation of substance p by gaba analogs and methods relating thereto
AU3938299A (en)	1999-12-13	Method of altering heartbeat
AU7876900A (en)	2001-04-30	Antisense modulation of fra-1 expression
AU4671000A (en)	2000-11-17	Method of enhancing insulin action
AU5737498A (en)	1998-09-10	Method for the preparation of alpha-bromo-lactam derivatives
AU7740100A (en)	2001-05-10	Efficient implementation of multiprecision arithmetic
AU1951701A (en)	2001-06-18	Methods for modulation of oocyte activation
AU2668201A (en)	2001-06-25	Method for the production of optically active cyanohydrins using r-oxynitrilase
AU2382601A (en)	2001-07-09	Novel method of treatment
AU1221101A (en)	2001-05-08	Antisense modulation of cytohesin-2expression
AU2002347652A1 (en)	2003-06-10	Process for the preparation of an enantiomerically enriched a-amino acid
AU6887198A (en)	1998-11-27	Improved method for the preparation of benzyluracils
AU8038400A (en)	2001-04-10	Method of treatment of influenza
AU1828399A (en)	1999-07-12	Novel formulations for the transdermal administration of asimadoline
AU2001250408A1 (en)	2001-10-08	Regulation of human serine racemase enzyme
HK1037191A (en)	2002-02-01	Process for the preparation of n-(phosphonomethyl)glycine by oxidizing n-substituted n-(phosphonomethyl)glycine

Legal Events

Date	Code	Title	Description
2002-03-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase